The role of single-nucleotide polymorphism rs10824026 of the SYNPO2L gene in the development of atrial fibrillation in a study in the East-Siberian population


Cite item

Full Text

Abstract

Background. Atrial fibrillation (AF) is the most common type of heart rhythm disturbance, leading to the development of lifethreatening conditions, such as cardio embolism, heart failure, and even sudden cardiac death. In recent years, the genetic aspects of AF have been actively discussed. The largest number of genetic predictors of AF was identified after a full genome-wide association studies (GWAS). Given that so far no studies of the association of rs10824026 polymorphism of chromosome 10q22 with the development of AF have been conducted in the Russian population, we conducted this clinical study. Aim. Checking the associations of the development of AF with the single-nucleotide polymorphism rs10824026 of the SYNPO2L gene in the East-Siberian population. Materials and methods. The study design was formed in accordance with the National Standard of the Russian Federation Good Clinical Practice, GOST P 52379-2005. The study uses design - “case-control”. The main group of patients - patients with known cardiac arrhythmias by the type of AF (n=106, average age 57.0±9 years, men 49.4%, women 50.6%), the group was formed using the criteria of the World Health Organization and the European Society of cardiologists. The control group (n=105, average age 57.0±9 years, men - 50.0%, women - 50.0%) was selected by age and gender from the DNA bank of international studies MONICA (Multinational MONItoring of trends and determinants in cardiovascular disease) under a joint agreement with the Research Institute of Therapy and preventive medicine - Novosibirsk. DNA was isolated by phenol-chloroform extraction. Among other things, among the research methods, routine laboratory methods were used; instrumental data; and invasive tactics such as CAG. Results. As a result of clinical genetic testing, it was found that the frequency of G/G polymorphism of the SYNPO2L gene in patients with AF shows a statistically significant difference.

About the authors

Kseniia Yu. Shishkova

Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation

Email: tadtaeva93@mail.ru
Graduate Student Krasnoyarsk, Russia

Svetlana Yu. Nikulina

Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation

D. Sci. (Med.), Prof. Krasnoyarsk, Russia

Vladimir A. Shulman

Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation

D. Sci. (Med.), Prof Krasnoyarsk, Russia

Anna A. Chernova

Voino-Yasenetsky Krasnoyarsk State Medical University of the Ministry of Health of the Russian Federation

Email: anechkachernova@yandex.ru
D. Sci. (Med.) Krasnoyarsk, Russia

Vladimir N. Maksimov

Research Institute of Therapy and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences

Email: medik11@mail.ru
D. Sci. (Med.), Prof., Research Institute of Therapy and Preventive Medicine - Branch of the Institute of Cytology and Genetics Novosibirsk, Russia

Anna A. Gurazheva

Research Institute of Therapy and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences

Email: annapalna1@mail.ru
Research Assistant, Scientific Research Institute of Therapy and Preventive Medicine - branch Novosibirsk, Russia

References

  1. Ослопов В.Н., Ослопова Ю.В. 20 лет в поисках гена фибрилляции предсердий. Практическая медицина. 2013; 3 (71): 12-4.
  2. Chen L.Y, Benditt D.G, Alonso A. Atrial fibrillation and its association with sudden cardiac death. Circ J 2014; 78 (11):2588-93.
  3. Postma A.V, Dekker L.R, Soufan A.T et al. Developmental and genetic aspects of atrial fibrillation. Trends Cardiovasc Med 2009; 19 (4): 123-30.
  4. Magnani J.W, Rienstra M, Lin H et al. Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.Circulation 2011; 124 (18): 1893-982.
  5. Никулина C.Ю., Шульман В.А., Кузнецова О.О. и др. Клинико-генетические особенности фибрилляции предсердий. Рацион. фармакотерапия в кардиологии. 2008; 2: 13-8.
  6. Ellinor P.T, Yi B.A, MacRae C.A. Genetics of atrial fibrillation. Med Clin North Am 2008; 92 (1): 41-51.
  7. Campuzano O, Perez-Serra A, Iglesias A et al. Genetic basis of atrial fibrillation. Gen Dis 2016; 3 (4): 257-62.
  8. Roberts J.D, Hu D, Heckbert S.R et al. Genetic investigation into the paradoxical differential risk of atrial fibrillation among blacks and whites. JAMA Cardiol 2016; 1 (4): 442-50.
  9. Liu Y, Ni B, Lin Y et al. The rs3807989 G/A polymorphism in CAV1 is associated with the risk of atrial fibrillation in Chinese Han populations.Pacing Clin Electophysiol 2015; 38 (2): 164-70.
  10. Chalazan B, Mol D, Sridhar A et al. Genetic modulation of atrial fibrillation risk in a Hispanic/Latino cohort. PLoS One 2018; 13 (4).
  11. Noheria A, Kumar A, Wylie J.V et al. Catheter ablation vs anti-arrhythmic drug therapy for atrial fibrillation: a systematic review.Arch Intern Med 2008; 168: 581-6.
  12. Kirchhof P., Benussi S. и др. Рекомендации ESC по лечению пациентов с фибрилляцией предсердий, разработанные совместно c EACTS. Рос. кардиолог. журн. 2017; 7 (147).

Copyright (c) 2019 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies